Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.8.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Cash flows from operating activities:    
Net income (loss) $ 41,556 $ (2,296)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Gain on sale of assets, net of taxes (26,339)
Change in valuation allowance, income tax (19,473)
Depreciation 515 317
Amortization of loan origination and warrant expenses 10 18
Share-based compensation expense 46 1
Changes in operating assets and liabilities:    
Accounts receivable 4,657 167
Inventory 744 133
Prepaid and other assets 112
Accounts payable (1,653) 978
Accrued advertising and other allowances (1,517) (210)
Due to Mylan, Inc. and affiliates 319
Other current liabilities (67) 22
Assets held for sale (22)
Net cash used in operating activities (1,112) (870)
Cash flows from investing activities:    
Net proceeds from the sale of asset 40,825
Purchase of marketable securities (32,194)
Sale of marketable securities 8,518
Capital expenditures (202) (419)
Net cash provided by (used in) investing activities 16,947 (419)
Cash flows from financing activities:    
Payments to retire Notes (1,500)
Payments to acquire treasury stock (11,802)
Proceeds from exercise of warrants 69  
Proceeds from exercise of stock options 854
Net cash used in financing activities (12,379)
Net increase (decrease) in cash and cash equivalents 3,456 (1,289)
Cash and cash equivalents at beginning of period 441 1,664
Cash and cash equivalents at end of period 3,897 375
Supplemental disclosures of cash flow information:    
Interest paid 54 95
Income taxes paid 1,350
Non-cash investing activities:    
Escrow receivable 5,000
Net unrealized losses, investments in marketable securities $ 35